Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that has caused a global pandemic Coronavirus Disease 2019 (COVID-19). Currently, there are no effective treatments specifically for COVID-19 infection. The initial step in SARS-CoV-2 infection is attachment...
Main Authors: | Ping Su, Dongxu Zhai, Albert H. C. Wong, Fang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13041-022-00956-1 |
Similar Items
-
Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
by: Yu-Hang Zhang, et al.
Published: (2022-02-01) -
Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01) -
Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2021-05-01) -
Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2Research in context
by: Annarita Miluzio, et al.
Published: (2023-01-01) -
SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
by: Irina V. Astrakhantseva, et al.
Published: (2023-05-01)